These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 187201)

  • 1. The effect of alkylating agents on the activity of adenosine 3',5'-monophosphate-dependent protein kinase in Walker carcinoma cells.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Nov; 25(21):2365-70. PubMed ID: 187201
    [No Abstract]   [Full Text] [Related]  

  • 2. Alterations in adenosine 3', 5'-monophosphate-binding protein in Walker carcinoma cells sensitive or resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(16):1831-6. PubMed ID: 9089
    [No Abstract]   [Full Text] [Related]  

  • 3. Guanosine 3',5'-monophosphate and the action of alkylating agents.
    Tisdale MJ; Phillips BJ
    Chem Biol Interact; 1977 Dec; 19(3):375-81. PubMed ID: 202413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of alkylating agents and other anti-tumour agents on the intracellular level of adenosine 3',5'-monophosphate in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jul; 24(13-14):1271-6. PubMed ID: 167787
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of alkylating agents on adenosine 3',5'-monophosphate metabolism in Walker carcinoma.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1976 Aug; 25(15):1793-7. PubMed ID: 182174
    [No Abstract]   [Full Text] [Related]  

  • 6. Adenosine 3',5'-monophosphate phosphodiesterase activity in experimental animal tumours which are either sensitive or resistant to bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):205-10. PubMed ID: 163093
    [No Abstract]   [Full Text] [Related]  

  • 7. Cyclic nucleotide metabolism in Walker carcinoma cells resistant to alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1978 Mar; 27(6):947-52. PubMed ID: 207283
    [No Abstract]   [Full Text] [Related]  

  • 8. Inhibition of cyclic 3',5'-nucleotide phosphodiesterase-a possible mechanism of action of bifunctional alkylating agents.
    Tisdale MJ; Phillips BJ
    Biochem Pharmacol; 1975 Jan; 24(2):211-7. PubMed ID: 163094
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterisation of cyclic adenosine 3':5'-monophosphate phospodiesterase from Walker carcinoma sensitive and resistant to bifunctional alkylating agents.
    Tisdale MJ
    Biochim Biophys Acta; 1975 Jul; 397(1):134-43. PubMed ID: 238630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane as target of alkylating agents.
    Grunicke H; Doppler W; Hofmann J; Lindner H; Maly K; Oberhuber H; Ringsdorf H; Roberts JJ
    Adv Enzyme Regul; 1985; 24():247-61. PubMed ID: 2940819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclic AMP-dependent protein kinase: pivotal role in regulation of enzyme induction and growth.
    Insel PA; Bourne HR; Coffino P; Tomkins GM
    Science; 1975 Nov; 190(4217):896-8. PubMed ID: 171770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transplantable mouse tumor deficient in cyclic-AMP-dependent protein kinase activity.
    Hochman J; Katz A; Weinstein Y
    Eur J Cancer (1965); 1979 Jan; 15(1):11-6. PubMed ID: 217689
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative studies on cyclic AMP binding and protein kinase in cyclic AMP-responsive and -unresponsive Walker 256 mammary carcinomas.
    Cho-Chung YS; Clair T; Yi PN; Parkison C
    J Biol Chem; 1977 Sep; 252(18):6335-41. PubMed ID: 19471
    [No Abstract]   [Full Text] [Related]  

  • 14. Adenylate cyclase, cyclic adenosin 3':5'-monophosphate phosphodiesterase, and regression of Walker 256 mammary carcinoma.
    Cho-Chung YS; Newcomer SF
    Cancer Res; 1977 Dec; 37(12):4493-9. PubMed ID: 200352
    [No Abstract]   [Full Text] [Related]  

  • 15. Analogs of cyclic adenosine monophosphate: correlation of inhibition of Purkinje Neurons with Protein Kinase Activation.
    Siggins GR; Henriksen SJ
    Science; 1975 Aug; 189(4202):559-61. PubMed ID: 167439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of cell shape by adenosine 3' : 5' - phosphate in chinese hamster ovary cells: studies of cyclic nucleotide analogue action, protein kinase activation, and microtubule organization.
    Hsie AW; O'Neill JP; Li AP; Borman LS; Schröder CH; Kawashima K
    Adv Pathobiol; 1977; (6):181-91. PubMed ID: 197834
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of protein kinases forming acid-labile histone phosphates in Walker-256 carcinosarcoma cell nuclei.
    Smith DL; Chen CC; Bruegger BB; Holtz SL; Halpern RM; Smith RA
    Biochemistry; 1974 Aug; 13(18):3780-5. PubMed ID: 4368488
    [No Abstract]   [Full Text] [Related]  

  • 18. In vivo activation of cyclic adenosine 3':5'-phosphate-dependent protein kinase in Chinese hamster ovary cells treated with N-6, O-2'-diburyl cyclic adenosine 3':5'-phosphate.
    Li AP; Kawashima K; Hsie AW
    Biochem Biophys Res Commun; 1975 May; 64(2):507-13. PubMed ID: 167745
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of cyclic AMP on chromatin-bound protein kinases in WI-38 fibroblasts stimulated to proliferate.
    Bombik BM; Baserga R
    Biochim Biophys Acta; 1976 Sep; 442(3):343-57. PubMed ID: 183819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thymidylate synthetase of Walker carcinoma by chlorambucil. A possible mechanism of action.
    Srinivasan SK; Gupta VS; Howarth RE
    Biochem Pharmacol; 1977 Jun; 26(11):1027-32. PubMed ID: 880254
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.